| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | omega-3-acid ethyl esters/alpha-tocopherol (Omacor®) |
| Formulation | 1000 mg capsule |
| Reference number | 230 |
| Indication | Adjuvant treatment in secondary prevention after myocardial infarction, in addition to other standard therapy and treatment of endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate |
| Company | Abbott Healthcare Products Ltd |
| BNF chapter | Cardiovascular system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 12/03/2003 |